(S)-(+)-2-氧代-4-苯基-3-恶唑烷乙酸

(S)-(+)-2-氧代-4-苯基-3-恶唑烷乙酸

CAS号：99333-54-7

英文名：2-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]acetic acid

分子式

C11H11NO4

熔点

103-105ºC(lit.)

密度

1.351

分子量

221.209

沸点

516.4ºC at 760mmHg

溶解度

信号词

危险品标志

若想填写更详细的询价信息，请点击进入询价页面

点我

基本信息

中文名称

(S)-(+)-2-氧代-4-苯基-3-恶唑烷乙酸

英文名称

2-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]acetic acid

中文别名

(S)-(4-苯基-1,3-恶唑烷酮)-2-乙酸、(S)-(2-氧代-4-苯基-1,3-噁唑啉-3-基)乙酸

英文别名

(S)-2-(2-oxo-4-phenyl-1,3-oxazolidin-3-yl)acetic acid、(S)-2-(2-Oxo-4-phenyloxazolidin-3-yl)acetic acid、(S)-(+)-(4-phenyl-2-oxo-oxazolidin-3-yl)acetic acid、(S)-(+)-2-Oxo-4-phenyl-3-oxazolidineacetic acid、(S)-(2-oxo-4-phenyl-oxazolidin-3-yl)-acetic acid、[(4S)-2-oxo-4-phenyloxazolidin-3-yl]acetic acid、(+)-(S)-(4-phenyl-2-oxo-1,3-oxazolidin-3-yl)acetic acid

CAS号

99333-54-7

分子式

C11H11NO4

分子量

221.209

精确质量

221.069

PSA

66.84

LOGP

1.2024

编号系统

PubChem号

24864372

MDL号

MFCD00192376

物化性质

密度

1.351

沸点

516.4ºC at 760mmHg

熔点

103-105ºC(lit.)

闪点

266.1ºC

折射率

1.579

下游产品

共找到43个下游商品 >

(+)-(3S,4R)-1-(2-bromophenyl)-3-[(S)-4-phenyl-2-oxo-1,3-oxazolidin-3-yl]-4-(E)-styryl-azetidin-2-one

(+)-(3S,4R)-1-(2-bromophenyl)-3-[(S)-4-phenyl-2-oxo-1,3-oxazolidin-3-yl]-4-(E)-styryl-azetidin-2-one

2-[(1S)-1,2,3,4-tetrahydroisoquinolin-1-ylmethyl]-2,3-dihydro-1H-isoindole-1,3-dione

2-[(1S)-1,2,3,4-tetrahydroisoquinolin-1-ylmethyl]-2,3-dihydro-1H-isoindole-1,3-dione

(R)-tert-butyl 3-((2R,3S)-2-((E)-3-iodostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoate

(R)-tert-butyl 3-((2R,3S)-2-((E)-3-iodostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoate

(R)-3-((2R,3S)-2-((E)-3-methylstyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoic acid

(R)-3-((2R,3S)-2-((E)-3-methylstyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoic acid

4-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-4-(3-trifluoromethyl-benzylcarbamoyl)-butyric acid tert-butyl ester

4-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-4-(3-trifluoromethyl-benzylcarbamoyl)-butyric acid tert-butyl ester

(S)-3-[(2R,3S)-1-(Bis-trimethylsilanyl-methyl)-2-methyl-4-oxo-azetidin-3-yl]-4-phenyl-oxazolidin-2-one

(S)-3-[(2R,3S)-1-(Bis-trimethylsilanyl-methyl)-2-methyl-4-oxo-azetidin-3-yl]-4-phenyl-oxazolidin-2-one

下游产品

(+)-(3S,4R)-1-(2-bromophenyl)-3-[(S)-4-phenyl-2-oxo-1,3-oxazolidin-3-yl]-4-(E)-styryl-azetidin-2-one 2-[(1S)-1,2,3,4-tetrahydroisoquinolin-1-ylmethyl]-2,3-dihydro-1H-isoindole-1,3-dione (R)-tert-butyl 3-((2R,3S)-2-((E)-3-iodostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoate (R)-3-((2R,3S)-2-((E)-3-methylstyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoic acid 4-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-4-(3-trifluoromethyl-benzylcarbamoyl)-butyric acid tert-butyl ester (S)-3-[(2R,3S)-1-(Bis-trimethylsilanyl-methyl)-2-methyl-4-oxo-azetidin-3-yl]-4-phenyl-oxazolidin-2-one (S)-3-((3S,4R)-1-Benzyl-2-oxo-4-phenyl-azetidin-3-yl)-4-phenyl-oxazolidin-2-one [2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-acetic acid benzyl ester [2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-acetic acid tert-butyl ester AVN 576 4-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-4-(3-trifluoromethyl-benzylcarbamoyl)-butyric acid tert-butyl ester (S)-3-[(2S,3R)-1-Benzyl-2-((E)-2-furan-2-yl-vinyl)-4-oxo-azetidin-3-yl]-4-phenyl-oxazolidin-2-one 1-benzyl-3β-[(S)-4-phenyloxazolidin-2-one-3-yl]-4β-hydroxymethylazetidin-2-one (R)-4-([1,4'-bipiperidin]-1'-yl)-2-((2R,3S)-2-((E)-3-fluorostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-N-((R)-1-phenylethyl)butanamide N-(2-fluoro-3-trifluoromethyl-benzyl)-3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-succinamic acid tert-butyl ester (R)-4-([1,4'-bipiperidin]-1'-yl)-2-((2R,3S)-2-((E)-3-methylstyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-N-((R)-1-phenylethyl)butanamide 5-(4-cyclohexyl-piperazin-1-yl)-5-oxo-2-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-pentanoic acid tert-butyl ester 1-benzyl-3β-(4(S)-phenyloxazolidin-2-one-3-yl)-4β-(3-methoxystyryl)azetidin-2-one (2S,3S)-1-Benzyl-2-methyl-4-oxo-3-((S)-2-oxo-4-phenyl-oxazolidin-3-yl)-azetidine-2-carboxylic acid methyl ester (S)-3-(3-bromo-2-oxopropyl)-4-phenyl-1,3-oxazolidin-2-one 3-[1,4']bipiperidinyl-1'-yl-3-oxo-2-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-(3-trifluoromethyl-benzyl)-propionamide (S)-3-((3S,4R)-1-Benzyl-2-oxo-4-phenethyl-azetidin-3-yl)-4-phenyl-oxazolidin-2-one (S)-2-[(2R,3S)-2-(2-Bromo-phenyl)-4-oxo-3-((S)-2-oxo-4-phenyl-oxazolidin-3-yl)-azetidin-1-yl]-propionic acid methyl ester 3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-[1-(3-trifluoromethyl-phenyl)-ethyl]-succinamic acid benzyl-(1S,2R)-2-[(1S)-1-[(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1,2,3,4-tetrahydroisoquinoline-2-carbonyl]cyclohexane-1-carboxylate benzyl(1S,2R)-2-[(1S)-1-[(1,3-dioxo-2,3-dihydro-1H-isoindol-2yl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-carbonyl]cyclopropane-1-carboxylate (S)-3-[(2R,3S)-1-Benzyl-2-methyl-4-oxo-2-((E)-styryl)-azetidin-3-yl]-4-phenyl-oxazolidin-2-one 3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-(1-phenyl-ethyl)-succinamic acid tert-butyl ester 5-(4-cyclohexyl-piperazin-1-yl)-5-oxo-2-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-pentanoic acid 3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-(1-phenyl-ethyl)-succinamic acid 3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-[1-(3-trifluoromethyl-phenyl)-ethyl]-succinamic acid (R)-tert-butyl 3-((2R,3S)-2-((E)-3-methylstyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoate (R)-tert-butyl 3-((2R,3S)-2-((E)-3-fluorostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoate N-(2-fluoro-3-trifluoromethyl-benzyl)-3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-succinamic acid N-methyl-3-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-(3-trifluoromethyl-benzyl)-succinamic acid tert-butyl ester 2-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-malonic acid tert-butyl ester 2,2,2-trichloro-ethyl ester SRX251 (1S,2R)-2-[(1S)-1-[(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-carbonyl]cyclohexane-1-carboxylic acid (R)-3-((2R,3S)-2-((E)-3-fluorostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoic acid 2-[2-oxo-3-(2-oxo-4-phenyl-oxazolidin-3-yl)-4-styryl-azetidin-1-yl]-N-(3-trifluoromethyl-benzyl)-malonamic acid tert-butyl ester (R)-3-((2R,3S)-2-((E)-3-iodostyryl)-4-oxo-3-((S)-2-oxo-4-phenyloxazolidin-3-yl)azetidin-1-yl)-4-oxo-4-(((R)-1-phenylethyl)amino)butanoic acid